Answers are grounded in this paper and cite their sources.
Prospective interventional study shows anti-VEGF improves vessel density and thickness in macular edema, indicating effective RVO treatment.
Background: To evaluate changes in retinal microvasculature in patients treated with anti-VEGF for macular edema secondary to branch retinal vein occlusion. A prospective interventional study at SMS Medical College & Hospital, Jaipur, enroll Methods: ed 55 patients with retinal vein occlusion. Participants underwent monthly injections of Ranibizumab for 6 months and were evaluated using OCT and OCTA for changes in central retinal thickness, parafoveal vessel density and FAZ area. Results: Parafoveal vessel density of superficial capillary plexus were significantly lower in eyes with branch retinal vein occlusion than in fellow eyes (p<0.001) and we found a significant increase in vessel density values after anti -VEGF treatment. The mean FAZ area was larger and irregular in eyes with branch retinal vein occlusion than in control eyes. (p<0.001). A significant decrease in central retinal thickness was also seen after anti VEGF injection. The age and gender distribution aligned with known demographic risks associated with RVO. Anti-VEGF therapy was effective in improving the structu Conclusion: ral and vascular integrity of the retina in RVO patients, as monitored through OCT and OCTA biomarkers. This study contributes to the growing body of evidence supporting the use of anti-VEGF agents in treating RVO and underscores the importance of advanced imaging techniques in evaluating treatment efficacy and guiding clinical decisions.
No takes yet. Share an insight, caveat, or question.
Sonwar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: